Summit Global Investments Purchases Shares of 8,085 Axcelis Technologies, Inc. $ACLS

Summit Global Investments acquired a new position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) in the third quarter, Holdings Channel.com reports. The institutional investor acquired 8,085 shares of the semiconductor company’s stock, valued at approximately $789,000.

A number of other large investors also recently modified their holdings of the stock. Salomon & Ludwin LLC purchased a new position in shares of Axcelis Technologies during the third quarter valued at approximately $25,000. EverSource Wealth Advisors LLC lifted its stake in Axcelis Technologies by 145.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock valued at $31,000 after acquiring an additional 267 shares in the last quarter. Strs Ohio bought a new position in Axcelis Technologies during the 3rd quarter valued at $49,000. Parkside Financial Bank & Trust boosted its holdings in Axcelis Technologies by 48.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,105 shares of the semiconductor company’s stock worth $77,000 after acquiring an additional 361 shares during the last quarter. Finally, CENTRAL TRUST Co grew its stake in shares of Axcelis Technologies by 1,094.7% in the 2nd quarter. CENTRAL TRUST Co now owns 1,350 shares of the semiconductor company’s stock worth $94,000 after acquiring an additional 1,237 shares in the last quarter. Institutional investors own 89.98% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on ACLS shares. Wall Street Zen lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Axcelis Technologies in a research report on Monday, December 22nd. Zacks Research downgraded Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a research note on Friday, December 5th. B. Riley increased their price target on Axcelis Technologies from $84.00 to $94.00 and gave the company a “neutral” rating in a research report on Wednesday, January 21st. Finally, Bank of America lifted their price target on Axcelis Technologies from $90.00 to $100.00 and gave the stock an “underperform” rating in a report on Tuesday, January 13th. Two equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Axcelis Technologies presently has a consensus rating of “Hold” and an average target price of $102.25.

Axcelis Technologies Stock Down 4.5%

Axcelis Technologies stock opened at $88.07 on Friday. The firm has a 50 day moving average price of $87.51 and a 200-day moving average price of $84.19. The company has a quick ratio of 3.32, a current ratio of 4.95 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a twelve month low of $40.40 and a twelve month high of $102.93. The company has a market capitalization of $2.70 billion, a P/E ratio of 20.82 and a beta of 1.73.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings results on Tuesday, November 4th. The semiconductor company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.20. Axcelis Technologies had a net margin of 15.93% and a return on equity of 14.58%. The company had revenue of $213.61 million for the quarter, compared to analysts’ expectations of $200.06 million. During the same quarter in the previous year, the firm posted $1.49 EPS. Axcelis Technologies’s revenue was down 16.8% on a year-over-year basis. Axcelis Technologies has set its Q4 2025 guidance at 1.120-1.120 EPS. As a group, equities analysts predict that Axcelis Technologies, Inc. will post 2.55 EPS for the current year.

Insiders Place Their Bets

In related news, Director Jorge Titinger sold 2,000 shares of the business’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $86.05, for a total value of $172,100.00. Following the sale, the director directly owned 7,477 shares in the company, valued at approximately $643,395.85. The trade was a 21.10% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Gerald M. Blumenstock sold 3,034 shares of the stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the transaction, the executive vice president owned 18,661 shares of the company’s stock, valued at $1,669,413.06. This represents a 13.98% decrease in their position. The SEC filing for this sale provides additional information. 0.48% of the stock is owned by corporate insiders.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.